402 related articles for article (PubMed ID: 35859595)
1. Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.
Mu D; Cheng J; Qiu L; Cheng X
Front Cardiovasc Med; 2022; 9():901990. PubMed ID: 35859595
[TBL] [Abstract][Full Text] [Related]
2. Copeptin in fluid disorders and stress.
Mu D; Ma C; Cheng J; Zou Y; Qiu L; Cheng X
Clin Chim Acta; 2022 Apr; 529():46-60. PubMed ID: 35143773
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin and Copeptin in health and disease.
Christ-Crain M
Rev Endocr Metab Disord; 2019 Sep; 20(3):283-294. PubMed ID: 31656992
[TBL] [Abstract][Full Text] [Related]
4. Copeptin - a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases.
Baranowska B; Kochanowski J
Neuro Endocrinol Lett; 2019 Dec; 40(5):207-214. PubMed ID: 32112544
[TBL] [Abstract][Full Text] [Related]
5. Copeptin: a biomarker of cardiovascular and renal function.
Morgenthaler NG
Congest Heart Fail; 2010 Jul; 16 Suppl 1():S37-44. PubMed ID: 20653710
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
[TBL] [Abstract][Full Text] [Related]
7. Arginine Vasopressin and Copeptin in Perinatology.
Evers KS; Wellmann S
Front Pediatr; 2016; 4():75. PubMed ID: 27532032
[TBL] [Abstract][Full Text] [Related]
8. Copeptin as a biomarker in heart failure.
Balling L; Gustafsson F
Biomark Med; 2014; 8(6):841-54. PubMed ID: 25224940
[TBL] [Abstract][Full Text] [Related]
9. Review novel insights into the diagnostic and prognostic function of copeptin in daily clinical practice.
Wu P; Wang L; Su X; Wang B; Cheng Y
Mol Biol Rep; 2023 Apr; 50(4):3755-3765. PubMed ID: 36662451
[TBL] [Abstract][Full Text] [Related]
10. The stress hormone copeptin: a new prognostic biomarker in acute illness.
Katan M; Christ-Crain M
Swiss Med Wkly; 2010; 140():w13101. PubMed ID: 20872295
[TBL] [Abstract][Full Text] [Related]
11. Copeptin and its potential role in diagnosis and prognosis of various diseases.
Dobsa L; Edozien KC
Biochem Med (Zagreb); 2013; 23(2):172-90. PubMed ID: 23894863
[TBL] [Abstract][Full Text] [Related]
12. Copeptin: Up-to-date diagnostic and prognostic role highlight.
Abdelmageed M; Güzelgül F
Anal Biochem; 2023 Jul; 673():115181. PubMed ID: 37247750
[TBL] [Abstract][Full Text] [Related]
13. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.
Christ-Crain M; Fenske W
Nat Rev Endocrinol; 2016 Mar; 12(3):168-76. PubMed ID: 26794439
[TBL] [Abstract][Full Text] [Related]
14. Gender and renal function influence plasma levels of copeptin in healthy individuals.
Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
[TBL] [Abstract][Full Text] [Related]
15. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
[TBL] [Abstract][Full Text] [Related]
16. Copeptin: clinical use of a new biomarker.
Morgenthaler NG; Struck J; Jochberger S; Dünser MW
Trends Endocrinol Metab; 2008 Mar; 19(2):43-9. PubMed ID: 18291667
[TBL] [Abstract][Full Text] [Related]
17. Copeptin and cardiovascular disease: a review of a novel neurohormone.
Yalta K; Yalta T; Sivri N; Yetkin E
Int J Cardiol; 2013 Sep; 167(5):1750-9. PubMed ID: 23298558
[TBL] [Abstract][Full Text] [Related]
18. Approach to the Patient: "Utility of the Copeptin Assay".
Christ-Crain M; Refardt J; Winzeler B
J Clin Endocrinol Metab; 2022 May; 107(6):1727-1738. PubMed ID: 35137148
[TBL] [Abstract][Full Text] [Related]
19. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.
Wannamethee SG; Welsh P; Whincup PH; Lennon L; Papacosta O; Sattar N
Eur J Heart Fail; 2014 Jan; 16(1):25-32. PubMed ID: 23901058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
